Canopy Growth (CGC) EBT Margin (QoQ) (2019 - 2025)
Canopy Growth (CGC) EBT Margin (QoQ) (2019 - 2025) Analysis & Trends
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - |
| 10 | Canopy Growth | 449.71 Mn | 202.70 Mn | 16.08 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -4,315.00 |
| Sep 30, 2025 | 5,464.00 |
| Dec 31, 2024 | 4,690.00 |
| Sep 30, 2024 | -2,402.00 |
| Jun 30, 2024 | 5,554.00 |
| Mar 31, 2024 | 7,132.00 |
| Dec 31, 2023 | -9,843.00 |
| Sep 30, 2023 | -17,088.00 |
| Jun 30, 2023 | 50,873.00 |
| Mar 31, 2023 | -25,103.00 |
| Dec 31, 2022 | -5,486.00 |
| Sep 30, 2022 | 154,549.00 |
| Jun 30, 2022 | -191,113.00 |
| Mar 31, 2022 | 22,621.00 |
| Dec 31, 2021 | -5,975.00 |
| Sep 30, 2021 | -30,329.00 |
| Jun 30, 2021 | 65,153.00 |
| Mar 31, 2021 | 449,822.00 |
| Dec 31, 2020 | -479,036.00 |
| Sep 30, 2020 | 3,933.00 |